Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial

Fig. 2

Outcomes among patients who were randomly assigned to the IC + CCRT and CCRT groups. IC: induction chemotherapy; CCRT: concurrent chemoradiotherapy; TPF: paclitaxel, cisplatin, and 5-fluorouracil. Responders and non-responders: Responders were defined as having more than 80% regression at a dose of 50Gy or more than 30% regression after IC, otherwise they were defined as non-responders; cCR: clinical complete regression

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us